332
Participants
Start Date
March 31, 2011
Primary Completion Date
August 31, 2012
Study Completion Date
August 31, 2012
Sofosbuvir
Sofosbuvir (SOF) administered as a 400 mg tablet orally once daily
RBV
Ribavirin (RBV) tablets administered orally in a divided daily dose according to package insert weight-based dosing recommendations (\< 75kg = 1000 mg and ≥ 75 kg = 1200 mg)
PEG
Pegylated interferon alfa-2a (PEG) 180 μg administered once weekly by subcutaneous injection
Concorde Medical Group, New York
New York Presbyterian Hospital, New York
Mt. Sinai Medical Center, New York
North Shore University Hospital, Manhasset
Clinical Associates Research, Reisterstown
Investigative Clinical Research, Annapolis
Digestive and Liver Disease Specialist, Norfolk
Asheville Gastroenterology Associates, Asheville
Columbia Gastroenterology Associates, Columbia
Gastrointestinal Specialists of Georgia, Marietta
Atlanta Gastroenterology Associates, Atlanta
University of Florida College of Medicine, Gainesville
Avail Clinical Research, DeLand
Orlando Immunology Center, Orlando
Internal Medicine Specialists, Orlando
South Florida Center of Gastroenterology, Wellington
Pointe West Infectious Disease, Bradenton
Advanced Research Institute, Trinity
Alabama Liver and Digestive Specialist, Montgomery
University of Cincinnati, Cincinnati
Henry Ford Health System, Novi
University of Chicago Medical Center, Chicago
St. Louis University Gastroenterology and Hepatology Clinical Research, St Louis
Clopton Clinic, Jonesboro
Baylor University, Dallas
North Texas Research Institute, Arlington
Baylor/ St. Luke's Advanced Liver Therapy, Houston
Alamo Medical Research, San Antonio
Central Texas Cinical Research, Austin
University of Colorado Denver Transplant Center and Hepatology Clinic, Aurora
South Denver Gastreoenterology, Englewood
University of New Mexico Health Science Center, Albuquerque
Cedars Sinai Medical Center, Los Angeles
Providence Clinical Research, Burbank
eStudy Site, Oceanside
Desta Digestive Disease Medical Center, San Diego
Southern California Liver Centers, Coronado
Medical Associates Reseach Group, San Diego
Kaiser Permanente Hepatology Research, San Diego
Advanced Clinical Research Institute, Anaheim
Virginia Mason Medical Center, Seattle
Beth Israel Deconess Medical Center, Boston
U Mass Memorial Medical Center, Worcester
Duke University Medical Center, Durham
Fundacion de Investigacion de Diego, San Juan
University Of Puerto Rico, San Juan
Lead Sponsor
Gilead Sciences
INDUSTRY